Oncology Hematology Care, Inc.

Summary

Oncology Hematology Care, Inc. is a medical facility located in Cincinnati, Ohio. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Multiple Myeloma, Lymphoma and other specialties. Oncology Hematology Care, Inc. is involved with conducting 297 clinical trials across 285 conditions. There are 11 research doctors associated with this hospital, such as Howard M. Gross, Kruti Patel, David M Waterhouse, and Dr. James Essell.

Top PIs

Clinical Trials running at Oncology Hematology Care, Inc.

Multiple Myeloma

Non-Hodgkin's Lymphoma

Lung Cancer

Breast Cancer

Lymphoma

Cancer

Laryngeal Cancer

Small Cell Lung Cancer

Ovarian Cancer

Chronic Lymphocytic Leukemia

Mezigdomide Combo vs. Pomalidomide Combo

for Multiple Myeloma

This trial is testing two drug combinations to find out which one is better and safer for patients with multiple myeloma that has come back or not responded to previous treatments. The drugs work together to kill cancer cells by stopping their growth, helping the immune system attack them, and making it harder for them to survive.

Recruiting

2 awards

Phase 3

Tec-DR and Tal-DR

for Multiple Myeloma

This trial is testing two new drug combinations to see if they work better than the current standard treatment for multiple myeloma. The new treatments aim to help the immune system find and destroy cancer cells more effectively.

Recruiting

2 awards

Phase 3

5 criteria

Anitocabtagene Autoleucel

for Multiple Myeloma

The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in participants with RRMM.

Recruiting

2 awards

Phase 3

3 criteria